Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100QFOG
Period2022-01-01 → 2022-12-31
Filed2023-03-23
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed

Amended by S100QG6E (2023-03-24).

Key figures · 100
MetricValuePeriodScopeSource row
Revenue¥10.0bn2022-01-01 → 2022-12-31Cons.Net sales
Operating income¥2.0bn2022-01-01 → 2022-12-31Cons.Operating income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥2.1bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥1.2bn2022-01-01 → 2022-12-31Cons.Profit loss
Total assets¥10.4bnat 2022-12-31Cons.Assets
Total liabilities¥1.9bnat 2022-12-31Cons.Liabilities
Net assets / equity¥8.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2021-12-31Cons.Net assets
Cash and deposits¥6.3bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.3bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2021-12-31Cons.Cash and cash equivalents
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥47m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥628m2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥30.22022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥204.83at 2022-12-31Cons.Net assets per share (5-year summary)
Equity ratio77.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31Cons.Rate of return on equity (5-year summary)
Employees122at 2022-12-31Cons.Number of employees
Revenue¥10.0bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥8.3bn2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥3.0bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.8bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥3.8bn2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income¥2.0bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income¥1.0bn2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income¥2.0bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥1.0bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income−¥4.6bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥2.7bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥2.1bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax¥1.0bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income¥1.2bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥2.0bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income−¥2.8bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥10.4bnat 2022-12-31StandaloneAssets
Total assets¥8.5bnat 2021-12-31StandaloneAssets
Total assets¥6.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥5.3bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥6.2bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.9bnat 2022-12-31StandaloneLiabilities
Total liabilities¥1.7bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥8.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥6.7bnat 2021-12-31StandaloneNet assets
Net assets / equity¥4.7bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥4.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥4.9bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥6.3bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥3.9bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31StandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.8bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.9bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥4.8bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥4.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥2.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥160m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥26m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.7bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-124.132020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-189.032019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-165.542018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥204.95at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥105.76at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥143.07at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥212.23at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio77.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.7%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio70.1%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31StandaloneRate of return on equity (5-year summary)
Shares issued39,603,606at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued38,202,956at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued26,437,681at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued83,398,924at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees118at 2022-12-31StandaloneNumber of employees
Employees141at 2021-12-31StandaloneNumber of employees
Employees127at 2020-12-31dStandaloneNumber of employees
Employees107at 2019-12-31dStandaloneNumber of employees
Employees90at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2022-12-31122 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,061
ItemContextValueUnit
Valuation and translation adjustmentsCurrentYearInstant243000JPY
Subscription rights to sharesCurrentYearInstant411672000JPY
Net assetsCurrentYearInstant8506092000JPY
Liabilities and net assetsCurrentYearInstant10433347000JPY
Net salesCurrentYearDuration10008338000JPY
Cost of salesCurrentYearDuration2408434000JPY
Gross profitCurrentYearDuration7599904000JPY
Selling general and administrative expensesCurrentYearDuration5636278000JPY
Operating incomeCurrentYearDuration1963625000JPY
Interest income noiCurrentYearDuration98000JPY
Foreign exchange gains noiCurrentYearDuration136179000JPY
Other noiCurrentYearDuration2925000JPY
Non operating incomeCurrentYearDuration139204000JPY
Commission fee noeCurrentYearDuration56543000JPY
Stock issuance cost noeCurrentYearDuration45867000JPY
Other noeCurrentYearDuration540000JPY
Non operating expensesCurrentYearDuration102951000JPY
Ordinary incomeCurrentYearDuration1999878000JPY
Gain on reversal of subscription rights to shares eiCurrentYearDuration106401000JPY
Extraordinary incomeCurrentYearDuration106401000JPY
Income before income taxesCurrentYearDuration2106279000JPY
Income taxes currentCurrentYearDuration396010000JPY
Income taxes deferredCurrentYearDuration531030000JPY
Income taxesCurrentYearDuration927041000JPY
Profit lossCurrentYearDuration1179238000JPY
Profit loss attributable to non controlling interestsCurrentYearDuration－JPY
Profit loss attributable to owners of parentCurrentYearDuration1179238000JPY
Profit lossCurrentYearDuration1179238000JPY
Foreign currency translation adjustment net of tax ociCurrentYearDuration198000JPY
Other comprehensive incomeCurrentYearDuration198000JPY
Comprehensive incomeCurrentYearDuration1179437000JPY
Comprehensive income attributable to owners of the parentCurrentYearDuration1179437000JPY
Comprehensive income attributable to non controlling interestsCurrentYearDuration－JPY
Net assetsPrior1YearInstant_CapitalStockMember17157628000JPY
Net assetsPrior1YearInstant_CapitalSurplusMember17132501000JPY
Net assetsPrior1YearInstant_RetainedEarningsMember-27975902000JPY
Net assetsPrior1YearInstant_TreasuryStockMember-86045000JPY
Net assetsPrior1YearInstant_ShareholdersEquityMember6228181000JPY
Cumulative effects of changes in accounting policiesPrior1YearInstant_RetainedEarningsMember-92822000JPY
Cumulative effects of changes in accounting policiesPrior1YearInstant_ShareholdersEquityMember-92822000JPY
Restated balancePrior1YearInstant_CapitalStockMember17157628000JPY
Restated balancePrior1YearInstant_CapitalSurplusMember17132501000JPY
Restated balancePrior1YearInstant_RetainedEarningsMember-28068725000JPY
Restated balancePrior1YearInstant_TreasuryStockMember-86045000JPY
Restated balancePrior1YearInstant_ShareholdersEquityMember6135358000JPY
Issuance of new sharesCurrentYearDuration_CapitalStockMember331000000JPY
Issuance of new sharesCurrentYearDuration_CapitalSurplusMember331000000JPY
Issuance of new sharesCurrentYearDuration_ShareholdersEquityMember662000000JPY
Issuance of new sharesexercise of subscription rights to sharesCurrentYearDuration_CapitalStockMember59831000JPY
Issuance of new sharesexercise of subscription rights to sharesCurrentYearDuration_CapitalSurplusMember59831000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 17 of 17 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identitynon_consolidated 2021-12-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass